Pfizer Incorporated is a pharmaceutical company, ranking number one in sales in the world. The company is based in New York City, with its research headquarters in Groton, Connecticut.

 It produces Lipitor (atorvastatin, used to lower blood cholesterol); the neuropathic pain/fibromyalgia drug Lyrica (pregabalin); the oral antifungal medication Diflucan (fluconazole), antibiotic Zithromax (azithromycin), Viagra (sildenafil citrate), and the anti inflammatory Celebrex (celecoxib) (also known as Celebra in some countries outside USA and Canada, mainly in South America).
Pfizer’s shares were made a component of the Dow Jones Industrial Average on April 8, 2004.
On January 26, 2009, Pfizer agreed to buy pharmaceutical giant Wyeth for US$68 billion, a deal financed with cash, shares and loans.
Founded Brooklyn, NY, USA (1849)
Headquarters  New York City, NY, USA
Key people Jeff Kindler, CEO
David Shedlarz, VC
Ian Read, Pres. of Pharma.
Martin Mackay, Pres. of R&D
Industry Health Care
Products Accupril
Lipitor
Viagra
See complete products listing.
Revenue ▲$48.418 billion USD (2007)
Net income ▲$8.144 billion USD (2007)[1]
Employees 86,600 (2008)[2]
Website www.pfizer.com
History
Pfizer is named after German-American cousins Charles Pfizer and Charles Erhardt (they were originally from Ludwigsburg, Germany) who launched a fine chemicals business, Charles Pfizer and Company, from a building at the intersection of Harrison Avenue and Bartlett Street[4] in Williamsburg, Brooklyn in 1849. There, they produced an antiparasitic called santonin. This was an immediate success, although it was the production of citric acid that really kick-started Pfizer’s growth in the 1880s. Pfizer continued to buy property to expand its lab and factory on the block bounded by Bartlett Street; Harrison Avenue; Gerry Street; and Flushing Avenue. That facility was used by Pfizer until 2005, when Pfizer closed its original plant along with several others. Pfizer established its original administrative headquarters at 81 Maiden Lane in Manhattan[4]. By 1906, sales totaled nearly $3 million.
World War I caused a shortage of calcium citrate that Pfizer imported from Italy for the manufacture of citric acid, and the company began a search for an alternative supply. Pfizer chemists learned of a fungus that ferments sugar to citric acid and were able to commercialize production of citric acid from this source in 1919. As a result Pfizer developed expertise in fermentation technology. These skills were applied to the mass production of penicillin during World War II, in response to a need from the U.S. government. The antibiotic was needed to treat injured Allied soldiers. In fact, most of the penicillin that went ashore with the troops on D-Day was made by Pfizer.
Following the success of penicillin production in the 1940s, penicillin became very inexpensive and Pfizer made very little profit for its efforts. As a result, in the late 1940s Pfizer decided to search for new antibiotics with greater profit potential. The discovery and commercialization of Terramycin (oxytetracycline) by Pfizer in 1950 moved the company on the path of change from a manufacturer of fine chemicals to a research-based pharmaceutical company. To augment its research in fermentation technology, Pfizer began a program to discover drugs through chemical synthesis. Pfizer also established an animal health division in 1959 with an 700-acre farm and research facility in Terre Haute, Indiana.
By the 1950s, Pfizer was established in Belgium, Brazil, Canada, Cuba, Iran, Mexico, Panama, Puerto Rico, Turkey and the United Kingdom. In 1960, the Company moved its medical research laboratory operations to a new facility in Groton, Connecticut. In 1980 Pfizer launched Feldene® (piroxicam), a prescription anti-inflammatory medication that became Pfizer’s first product to reach a total of a billion United States dollars in sales.
During the 1980s and 1990s Pfizer underwent a period of growth sustained by the discovery and marketing of (Zoloft, Lipitor, Norvasc, Zithromax, Aricept, Diflucan, Viagra). Pfizer has recently grown by mergers, including those with Warner-Lambert (2000), with Pharmacia (2003), and an agreement to merge with Wyeth (2009).

Popularity: 14% [?]